Brain Injury Clinical Trial
Official title:
The Impact of Intraoperative Microemboli Load on Postoperative Brain Injury in Patients Undergoing Aortic Valve Replacement Preformed With Two Different Surgical Approaches
Postoperative brain damage and neuropsychological disorders have been observed in 30 - 80 %
of patients after heart surgery with the use of cardiopulmonary bypass (CPB).They can
persist up to a year after cardiac surgery and are associated with increased hospital
mortality and prolonged intrahospital stay.
Hypoperfusion,hyperthermia,atrial fibrillation,genetic predisposition and systemic
inflammatory response associated with CPB have been identified as pathophysiological
mechanisms.However, some authors consider cerebral embolisation to be the prevalent
mechanism of intraoperative brain injury after cardiac surgery,as gaseous or solid cerebral
emboli can cause ischemia, inflammation and edema,consequently causing cerebral infarctions
usually resulting with stroke,coma,encephalopathy, delirium and cognitive decline.
Additionally,they may impair cerebrovascular reactivity (CVR).
Aortic valve replacement (AVR) preformed by full sternotomy is the standard approach in the
treatment of aortic valve disease. Minimally invasive (MIS) aortic valve replacement has
been shown to reduce postoperative mortality, morbidity, and pain while providing faster
recovery, a shorter hospital stay, and better cosmetic results. However, due to technically
more demanding procedure, MIS may lead to prolonged CPB time and incomplete de-airing of the
heart with an increased risk for cerebral gas embolization. Therefore, the choice of MIS
might bear an augmented risk for brain injury.
Transcranial Doppler (TCD) enables real time detection of intraoperative emboli in the
cerebral arteries seen as microembolic signals (MES), and is an essential neuromonitoring
tool. Several studies demonstrated correlation between the number of MES and the occurrence
as well as severity of postoperative neurological complications. However, the factors
contributing to brain injury have not been elucidated in those studies. The investigators
speculate that impairment of CVR is an important mechanism that persists and prolongs the
duration of brain injury into postoperative period.
The aim of the study is to compare two surgical approaches used for AVR, with focus on the
number of MES and their impact on levels of protein S100B (marker of brain tissue
damage),postoperative CVR and cognitive function With the results,the investigators aim to
help surgeons in selecting the appropriate technique for AVR in individual participants,as
well as to clarify the effect of aortic valve surgery on the brain.
Patients undergoing for aortic valve replacement will be enrolled in the study after giving the signed informed consent and will be divided in two groups depending on the type of the surgical technique. Either full sternotomy (FS) or minimal invasive sternotomy (MIS) will be performed, both with the use of cardio-pulmonary bypass (CPB).One week before and one week after the surgery patients will undergo mini mental test and measurement of visually evoked cerebral blood flow velocity response (VEFR).Levels of S100B, interleukin (IL) 1, IL 6, IL 8, IL 10 and microparticles will be determined before induction of anesthesia,as well as 6 h, 24 h, 48 h and 7 days after CPB.Each patient will have invasive and non invasive monitoring that will include near infrared spectroscopy (NIRS), bispectral index (BIS) and TCD during surgery.MES will be detected using TCD at the following time-points: beginning of surgery, after sternotomy, during aortic cannulation, during CPB, during de-airing, opening of the clamp on the aorta and after CBP removal before chest closure.All of this data will be documented as well as the demographic characteristics of patients, their preoperative medical status, and intraoperative data (duration of surgery, duration of CPB, hemodynamic parameters, inotropic/vasoactive support,blood and blood components); duration of mechanical ventilation in intensive care unit (ICU), duration of ICU stay, 30-day mortality and morbidity, as well as postoperative complications. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02710123 -
Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion
|
N/A | |
Recruiting |
NCT02777060 -
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
|
N/A | |
Completed |
NCT02262286 -
MIND (Management of Traumatic Brain Injury Diagnosis)
|
N/A | |
Completed |
NCT01461902 -
Vasospasm in Pediatric Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT01198964 -
Optimization of Human Cortical Stimulation
|
||
Active, not recruiting |
NCT01207050 -
Effect of Rozerem on Sleep Among People With Traumatic Brain Injury
|
Phase 4 | |
Completed |
NCT01201863 -
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
|
Phase 4 | |
Completed |
NCT00875329 -
Traumatic Brain Injury (TBI) Screening Instruments
|
N/A | |
Completed |
NCT01035606 -
Training in Goal-directed Attention Regulation for Individuals With Brain Injury
|
N/A | |
Completed |
NCT01059890 -
Cerebral Antibiotics Distribution After Acute Brain Injury
|
Phase 1 | |
Completed |
NCT00596765 -
Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury
|
N/A | |
Completed |
NCT00571623 -
Automated Chest Physiotherapy to Improve Outcomes in Neuro
|
N/A | |
Completed |
NCT00336466 -
The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)
|
Phase 2 | |
Recruiting |
NCT05105763 -
Biofeedback Gait Retraining for Stiff Knee Gait Correction
|
N/A | |
Recruiting |
NCT02495558 -
Cough Assessment in Patients With Severe Acquired Brain Injury
|
N/A | |
Completed |
NCT02100592 -
Early Verticalization in neuroICU With ERIGO: a Safety and Feasibility Study
|
Phase 1/Phase 2 | |
Completed |
NCT00797680 -
Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest
|
Phase 2 | |
Completed |
NCT00018499 -
Genotype Influence on Recovery After Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT02567201 -
Electrophysiological Evaluation of Voluntary Attention
|
N/A | |
Withdrawn |
NCT05581927 -
Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE)
|
N/A |